Navigating Biosimilars:
Translating Evidence Into Clinical Practice

This course was last updated on
March 30, 2018
CME credit has expired.

Leonard Calabrese, DO, and Steven Feldman, MD, PhD, provide their insights into the dynamic world of biosimilars, first highlighting key features of biologics and the rigorous scientific requirements for demonstrating biosimilarity.


Steven R. Feldman, MD, PhD
Steven R. Feldman, MD, PhD
Professor of Dermatology, Pathology and Public Health Sciences
Department of Dermatology
Wake Forest School of Medicine
Winston-Salem, North Carolina
Leonard Calabrese, DO
Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director, RJ Fasenmyer Center for Clinical Immunology
Cleveland Clinic
Cleveland, Ohio

Enter your information to begin.

Content Areas

  • Patient Education
  • Complexity of Biologics
  • Regulatory Pathways
  • Extrapolation of Indications
  • Clinical Implications
  • Patient Access and Affordable Care Act

Cme credit

Available Credit: 1.50 AMA PRA Category 1 Credits™.
1.50 ACPE Contact Hours
Opens: March 30, 2018
Expires: March 29, 2019
Target Audience: Dermatologists
Other Healthcare Providers
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.